These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8016888)

  • 21. Ultrastructural changes in Langerhans cells in gingival overgrowth in cyclosporin A-treated renal transplant patients.
    Mariani G; Calastrini C; Aleotti A; Carnevale E; Stabellini G
    Pathology; 2004 Jun; 36(3):242-6. PubMed ID: 15203728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategy for improving retransplantation in the CyA era.
    Dickerman R; Langley J; Brinker K; Trevino G; Melton L; Vergne-Marini P; Wilson PK
    Transplant Proc; 1993 Feb; 25(1 Pt 1):257-8. PubMed ID: 8438292
    [No Abstract]   [Full Text] [Related]  

  • 23. Synergism between nifedipine and cyclosporine A on the incorporation of [35S]sulfate into human gingival fibroblast cultures in vitro.
    Flynn JC; Henderson JS; Johnson RB
    J Periodontal Res; 2006 Aug; 41(4):316-21. PubMed ID: 16827726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin-6 gene polymorphism in renal transplant patients with and without gingival overgrowth.
    Drozdzik M; Kurzawski M; Drozdzik A; Kotrych K; Banach J; Pawlik A
    J Clin Periodontol; 2005 Sep; 32(9):955-8. PubMed ID: 16104959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of collagen type I in fibroblast-keratinocyte cocultures emphasizes the decisive role of fibroblasts in the manifestation of the phenotype of cyclosporin A-induced gingival overgrowth.
    Dannewitz B; Tomakidi P; Syagailo Y; Kohl A; Staehle HJ; Eickholz P; Komposch G; Steinberg T
    J Periodontal Res; 2009 Feb; 44(1):62-72. PubMed ID: 18973541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gingival overgrowth in renal transplant recipients: a study concerning prevalence, severity, periodontal, and predisposing factors.
    Lima RB; Benini V; Sens YA
    Transplant Proc; 2008 Jun; 40(5):1425-8. PubMed ID: 18589122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimerism in survivors following allograft renal transplantation.
    Lee JM; Lee CJ; Hu CY; Hsieh RP; Hu RH; Lee PH; Luh SP; Lee YC; Chu SH
    Transplant Proc; 1996 Jun; 28(3):1285-7. PubMed ID: 8658662
    [No Abstract]   [Full Text] [Related]  

  • 29. Kidney transplantation: generic HLA DR compatibility reduces acute rejection episodes.
    Reviron D; Mercier P; Jaber K; Dussol B; Brunet P; Berland Y
    Transplant Proc; 1996 Oct; 28(5):2812-3. PubMed ID: 8908073
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between gingival hyperplasia and class II histocompatibility antigens in renal transplant recipients.
    Türkmen A; Ak G; Furuncuoglu Y; Akar U; Seyhun Y; Türk S; Carin M; Sever MS
    Nephron; 2000 Jan; 84(1):29-31. PubMed ID: 10644905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients.
    Condé SA; Aarestrup FM; Vieira BJ; Bastos MG
    Transplant Proc; 2008 Jun; 40(5):1435-8. PubMed ID: 18589124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin-induced gingival hyperplasia: an ultrastructural study of the oral epithelial prickle cells.
    Belazi M; Thomopoulos GN; Markopoulos AK; Papanayotou P
    J Submicrosc Cytol Pathol; 1993 Oct; 25(4):591-601. PubMed ID: 8269406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug-induced gingival hyperplasia].
    Nohl F; Ferrari P
    Ther Umsch; 1998 Sep; 55(9):573-5. PubMed ID: 9789475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ; Bayne AM; Welsh KI; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced gingival overgrowth.
    Seymour RA
    Adverse Drug React Toxicol Rev; 1993; 12(4):215-32. PubMed ID: 8142576
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period.
    Frei U; Bode U; Repp H; Schindler R; Brunkhorst R; Vogt P; Hauss J; Pichlmayr R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1394-6. PubMed ID: 8442152
    [No Abstract]   [Full Text] [Related]  

  • 37. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
    Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
    Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
    [No Abstract]   [Full Text] [Related]  

  • 38. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal transplantation: nifedipine for the nonstarters? A prospective randomised study.
    Donnelly PK; Feehally J; Jurewicz A; Furness P; McCullough T; Harper SJ; Moorhouse J; Morgan J; Kehinde EO; Horsburgh T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):600-1. PubMed ID: 8438431
    [No Abstract]   [Full Text] [Related]  

  • 40. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.